NASDAQ: BOLDBoundless Bio Inc Stock Ownership - Who owns Boundless Bio?
Insider buying vs selling
Have Boundless Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Arch Venture Fund IX LP | 10% Owner | 2024-04-02 | 133,333 | $16.00 | $2.13MBuy |
| Arch Venture Fund IX LP | 10% Owner | 2024-04-02 | 66,667 | $16.00 | $1.07MBuy |
| Kristina Burow | Director | 2024-04-02 | 133,333 | $16.00 | $2.13MBuy |
| Kristina Burow | Director | 2024-04-02 | 66,667 | $16.00 | $1.07MBuy |
| Keith Crandell | 10% Owner | 2024-04-02 | 133,333 | $16.00 | $2.13MBuy |
| Keith Crandell | 10% Owner | 2024-04-02 | 66,667 | $16.00 | $1.07MBuy |
| Ra Capital Management LP | 10% Owner | 2024-04-02 | 15,625 | $16.00 | $250.00kBuy |
| Ra Capital Management LP | 10% Owner | 2024-04-02 | 296,875 | $16.00 | $4.75MBuy |
BOLD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BOLD insiders and whales buy or sell their stock.
BOLD Shareholders
What type of owners hold Boundless Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fmr LLC | 15.00% | 3,345,006 | $5.75M | Institution |
| Ra Capital Management LP | 9.78% | 2,180,631 | $3.75M | Institution |
| Nextech Invest Ltd | 5.51% | 1,228,069 | $2.11M | Institution |
| Arch Venture Fund IX LP | 5.30% | 1,181,766 | $2.03M | Insider |
| Keith Crandell | 5.30% | 1,181,766 | $2.03M | Insider |
| Kristina Burow | 5.30% | 1,181,766 | $2.03M | Insider |
| Citadel Advisors LLC | 3.55% | 790,639 | $1.36M | Institution |
| Redmile Group LLC | 3.32% | 740,204 | $1.27M | Institution |
| Sectoral Asset Management Inc | 3.04% | 678,574 | $1.17M | Institution |
| Jonathan E. Lim | 2.93% | 653,479 | $1.12M | Insider |
BOLD vs Biotech Stocks
Boundless Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.